Ellen Scheers

503 total citations
13 papers, 403 citations indexed

About

Ellen Scheers is a scholar working on Small Animals, Cancer Research and Oncology. According to data from OpenAlex, Ellen Scheers has authored 13 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Small Animals, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Ellen Scheers's work include Animal testing and alternatives (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Ellen Scheers is often cited by papers focused on Animal testing and alternatives (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Ellen Scheers collaborates with scholars based in Belgium, United States and Sweden. Ellen Scheers's co-authors include Paul J. Dierickx, Rao N. V. S. Mamidi, Filip Cuyckens, Damayanthi Devineni, Laurent Leclercq, Juthamas Sukbuntherng, Geert Mannens, Annouschka Laenen, Joe Murphy and Donna Skee and has published in prestigious journals such as Analytica Chimica Acta, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

Ellen Scheers

13 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Scheers Belgium	10	138	103	81	76	73	13	403
Nora Anderson United States	5	265 1.9×	94 0.9×	45 0.6×	36 0.5×	40 0.5×	8	601
Guoqiang Liu China	10	113 0.8×	55 0.5×	49 0.6×	39 0.5×	71 1.0×	31	401
Hiroyasu Imanishi Japan	16	183 1.3×	39 0.4×	63 0.8×	33 0.4×	67 0.9×	44	734
Katrijn Bogman Switzerland	10	192 1.4×	92 0.9×	98 1.2×	42 0.6×	317 4.3×	18	732
Brijesh Sutariya India	13	165 1.2×	119 1.2×	73 0.9×	12 0.2×	23 0.3×	21	475
Johanna C. Arroyave-Ospina Colombia	9	345 2.5×	105 1.0×	42 0.5×	26 0.3×	40 0.5×	20	740
Jolana Cermanová Czechia	15	81 0.6×	38 0.4×	67 0.8×	26 0.3×	207 2.8×	37	463
Huibin Lu China	11	287 2.1×	25 0.2×	79 1.0×	22 0.3×	59 0.8×	26	573
Ellen A. Cannady United States	11	87 0.6×	88 0.9×	121 1.5×	17 0.2×	103 1.4×	21	456
Christian Seelos Austria	13	227 1.6×	64 0.6×	41 0.5×	9 0.1×	54 0.7×	20	535

Countries citing papers authored by Ellen Scheers

Since Specialization

Citations

This map shows the geographic impact of Ellen Scheers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Scheers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Scheers more than expected).

Fields of papers citing papers by Ellen Scheers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Scheers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Scheers. The network helps show where Ellen Scheers may publish in the future.

Co-authorship network of co-authors of Ellen Scheers

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Scheers. A scholar is included among the top collaborators of Ellen Scheers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Scheers. Ellen Scheers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zwart, Loeckie De, Jan Snoeys, Frank Jacobs, et al.. (2021). Prediction of the drug–drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib. CPT Pharmacometrics & Systems Pharmacology. 10(9). 1107–1118. 11 indexed citations

Scheers, Ellen, Hilde Bohets, Italo Poggesi, et al.. (2020). Metabolism and disposition in rats, dogs, and humans of erdafitinib, an orally administered potent pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor. Xenobiotica. 51(2). 177–193. 10 indexed citations

Mamidi, Rao N. V. S., Shannon Dallas, Carlo Sensenhauser, et al.. (2016). In vitro and physiologically‐based pharmacokinetic based assessment of drug–drug interaction potential of canagliflozin. British Journal of Clinical Pharmacology. 83(5). 1082–1096. 22 indexed citations

Francke, Stephan, Rao N. V. S. Mamidi, Bhavna Solanki, et al.. (2015). In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humans. The Journal of Clinical Pharmacology. 55(9). 1061–1072. 41 indexed citations

Scheers, Ellen, Laurent Leclercq, Jan de Jong, et al.. (2014). Absorption, Metabolism, and Excretion of Oral 14C Radiolabeled Ibrutinib: An Open-Label, Phase I, Single-Dose Study in Healthy Men. Drug Metabolism and Disposition. 43(2). 289–297. 105 indexed citations

Mamidi, Rao N. V. S., Filip Cuyckens, Jie Chen, et al.. (2014). Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans. Drug Metabolism and Disposition. 42(5). 903–916. 56 indexed citations

Devineni, Damayanthi, Joseph Murphy, Shean‐Sheng Wang, et al.. (2014). Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants. Clinical Pharmacology in Drug Development. 4(4). 295–304. 30 indexed citations

Govaert, Yasmine, Adriana Pavesi Arisseto Bragotto, Joris Van Loco, et al.. (2005). Optimisation of a liquid chromatography–tandem mass spectrometric method for the determination of acrylamide in foods. Analytica Chimica Acta. 556(2). 275–280. 31 indexed citations

Dierickx, Paul J. & Ellen Scheers. (2002). Neutral red uptake inhibition in adhered and adhering rat hepatoma‐derived Fa32 cells to predict human toxicity. Journal of Applied Toxicology. 22(1). 61–65. 5 indexed citations

10.

Scheers, Ellen, Anna Forsby, & Paul J. Dierickx. (2002). Cytotoxicity of Amino Alcohols to Rat Hepatoma-derived Fa32 Cells. Alternatives to Laboratory Animals. 30(3). 309–312. 1 indexed citations

11.

Clemedson, Cecilia, Jørgen Clausen, Anna Forsby, et al.. (2002). Development of an In Vitro Test Battery for the Estimation of Acute Human Systemic Toxicity: An Outline of the EDIT Project. Alternatives to Laboratory Animals. 30(3). 313–321. 14 indexed citations

12.

Scheers, Ellen, et al.. (2001). In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity data. Toxicology in Vitro. 15(2). 153–161. 75 indexed citations

13.

Dierickx, Paul J., et al.. (2001). Cytotoxicity of the MEIC Reference Chemicals in Antioxidant-enriched Rat Hepatoma-derived Fa32 cells. Alternatives to Laboratory Animals. 29(3). 217–223. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact